Navigation Links
Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
Date:9/24/2007

DUBLIN, Ohio, Sept. 24 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced President and Chief Executive Officer (CEO) R. Kerry Clark will become chairman and CEO, effective Nov. 8 following the company's 2007 annual shareholder meeting. Clark, 55, succeeds Cardinal Health founder Robert D. Walter, 62, who plans to retire at the end of the company's 2008 fiscal year.

Since joining Cardinal Health in April 2006, Clark has continued the company's focus on serving health-care providers, divested businesses that fell outside this focus, acquired several companies to complement and grow core businesses and implemented organizational changes to improve operational performance.

Walter will serve as executive director until June 30, 2008, after which he will retire from the company but remain on the board.

"The time is right for Kerry to become chairman," Walter said. "Our transition has gone extremely well and the company is thriving under Kerry's leadership. I'm as confident as ever about Cardinal Health and its future."

John B. McCoy, presiding director of the board, said "Bob has worked closely with the board for many years to plan for his succession. We are grateful for his many years of service to Cardinal Health shareholders and are pleased with the direction Kerry is leading the company. Kerry is building on a strong foundation to create long-term value for Cardinal Health customers, employees and shareholders."

The chairmanship transition marks another milestone in Walter's distinguished career. As the longest-tenured chairman of a company the size of Cardinal Health, Walter grew the business from a small, regional food distributor to a diversified provider of health-care products and services and one of the largest companies in the world. An investment of $10,000 in Cardinal Health stock at the time of its public offering in 1983 would be worth $8.2 million in 2007, an appreciation of more than 80,000 percent.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(R) data mining services and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at http://www.cardinalhealth.com.

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the following: competitive pressures in its various lines of business; the loss of one or more key customer or supplier relationships or changes to the terms of those relationships; uncertainties relating to the timing of generic introductions and the frequency or rate of pharmaceutical price appreciation; changes in the distribution patterns or reimbursement rates for health-care products and/or services; the results, consequences, effects or timing of any inquiry or investigation by any regulatory authority or any legal and administrative proceedings; uncertainties related to finalizing the pending settlement of the class-action securities litigation, including obtaining court approval of the settlement; successful integration of Cardinal Health and VIASYS Healthcare and the ability to achieve synergies from the acquisition; and general economic and market conditions. This news release reflects management's views as of September 24, 2007. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward- looking statement.


'/>"/>
SOURCE Cardinal Health
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Calls For Legal Response Against Da Vinci Code
2. Poor health care in Russia maybe causing Decline in its Population
3. Startling Expose – Physicians Often Have No Regular Source Of Health Car
4. Debate Rages over firing of HIV infected health care workers
5. Want a Healthy brew? Have some Tea!
6. Patient’s perception of health status helps in better recover
7. Antioxidants protect health tissue in people undergoing radiation therapy.
8. Sexual abuse affect health for a lifetime
9. Smoking a greater risk than HIV? Yes say health experts!!!!
10. Healthcare sector is now a multi billion-dollar industry in India
11. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society , ... more than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, ... how to avoid this latter group, tune in to Lifestyle Magazine on ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination ... are complicated and require expert user knowledge. In a live webinar on April ... the simplified, yet highly accurate, determination of sodium. , It has long been ...
(Date:3/27/2017)... Irvine, CA (PRWEB) , ... March 27, 2017 ... ... company has entered a settlement agreement to resolve the pending litigation between itself ... Court for the District of Utah). , “I am thrilled to announce that ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 ... has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription opioids ...
(Date:3/27/2017)... , ... March 27, 2017 , ... Harris Communications, Inc., ... hearing, is bringing its latest products to the Deaf Seniors of America Conference, April ... the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and to ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Microplate Instrumentation ... ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
(Date:3/24/2017)... 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today disclosed ... Term Sheet (the "Definitive Financing") it entered into ... Company,s stockholders, who are referred to in the ... 8-K filed with the Securities and Exchange Commission. ...
Breaking Medicine Technology: